Throughout the study, the levels of CD133+CXCR4+CD34- cells were significantly higher in the group of DMD patients with a slow progressive disease course (mean value±SD: 31.36%±14.67% vs. 11.12%±4.9%; P<0.0001). This evidence concerns the gene CD34 and Duchenne muscular dystrophy.